Clinical trial
Dose Intensive Chemotherapy for Children Less Than Ten Years of Age Newly-Diagnosed With Malignant Brain Tumors: A Pilot Study of Two Alternative Intensive Induction Chemotherapy Regimens, Followed by Consolidation With Myeloablative Chemotherapy (Thiotepa and Carboplatin, With or Without Etoposide) and Autologous Stem Cell Rescue [HEAD START III]
NCT00392886 is registered in ClinicalTrials.gov with Children's Hospital Los Angeles as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dose Intensive Chemotherapy for Children Less Than Ten Years of Age Newly-Diagnosed With Malignant Brain Tumors: A Pilot Study of Two Alternative Intensive Induction Chemotherapy Regimens, Followed by Consolidation With Myeloablative Chemotherapy (Thiotepa and Carboplatin, With or Without Etoposide) and Autologous Stem Cell Rescue [HEAD START III]
- Lead sponsor
- Children's Hospital Los Angeles
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- March 31, 2004
- Completion date
- Not reported
- Enrollment
- 120 (estimated)
- Sites
- 37
Conditions
As the registry lists them; a condition with its own page is linked.
brain and central nervous system tumors